Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Soligenix, Inc. - Common Stock (NQ: SNGX )

2.310 -0.040 (-1.70%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,114
Open 2.300
Bid (Size) 2.250 (10)
Ask (Size) 2.400 (3)
Prev. Close 2.350
Today's Range 2.250 - 2.430
52wk Range 1.830 - 14.92
Shares Outstanding 2,509,499
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Soligenix Targets Psoriasis With New Therapy
Soligenix Targets Psoriasis With New Therapy 
Via News Direct
EXCLUSIVE: Soligenix's Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year
Soligenix's IIS study on HyBryte for cutaneous T-cell lymphoma shows 70% success and strong safety profile, with Phase 3 enrollment ongoing. 
Via Benzinga

Performance

YTD
-21.43%
-21.43%
1 Month
-27.81%
-27.81%
3 Month
-35.65%
-35.65%
6 Month
-25.24%
-25.24%
1 Year
-78.74%
-78.74%

More News

Read More
Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL
Via News Direct
EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer
Via Benzinga
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
Via News Direct
Soligenix Announces Participation at the Spartan Capital Investor Conference
Via TheNewswire.com
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Via ACCESSWIRE
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Soligenix Announces Participation at the Spartan Capital Investor Conference
Via NewMediaWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
7 Top Stocks Under $10: July 2024 Edition
Via InvestorPlace
MarketBeat Week in Review – 7/8 - 7/12
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Uncover Why This Pharma Stock Jumped 400% on Study Update
Via MarketBeat
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P 500 Edges Higher; Indivior Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.